Billiontoone (NASDAQ:BLLN) used its presentation at the JPMorgan Healthcare Conference to highlight what management described as a “single molecule” next-generation sequencing platform that it ...
Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...
Strategic partnership provides complete automation-friendly solution for IDT NGS workflows on Hamilton’s liquid handling systems and enables user choice for solid tumor, heme comprehensive genomic ...
Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Continued innovation of proprietary cell-free cloning technology has improved synthesis success rates, enabling pricing as low as $0.15 per base pair. SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, a ...
There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...
Global genomics leader Integrated DNA Technologies (IDT) today announced the relocation of its original Bay Area site from Redwood City to Sunnyvale. The strategic move marks an investment in IDT's ...
Next-generation DNA sequencing (NGS)—the same technology which is powering the development of tailor-made medicines, cancer diagnostics, infectious disease tracking, and gene research—could become a ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback